AAS
PFE icon

Asset Allocation Strategies’s Pfizer PFE Stock Holding History

Asset Allocation Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,284
Closed -$233K – 181
2026
Q1 		$233K Buy
+8,284
New +$221K 0.04% 155
2024
Q3 		– Sell
-7,679
Closed -$215K – 119
2024
Q2 		$215K Sell
7,679
-6,323
-45% -$174K 0.07% 86
2024
Q1 		$389K Buy
14,002
+772
+6% +$21.4K 0.14% 53
2023
Q4 		$381K Buy
13,230
+3,752
+40% +$113K 0.15% 49
2023
Q3 		$314K Buy
9,478
+207
+2% +$7.32K 0.15% 50
2023
Q2 		$340K Buy
9,271
+2,760
+42% +$107K 0.16% 50
2023
Q1 		$266K Buy
6,511
+88
+1% +$3.8K 0.77% 33
2022
Q4 		$329K Buy
+6,423
New +$308K 0.22% 45

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Asset Allocation Strategies's PFE Position: Q2 2026 in Review

Asset Allocation Strategies sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,284 shares — an estimated $233K sold.

Asset Allocation Strategies first reported a position in PFE in Q4 2022 and held it in 8 quarters. The position peaked at $389K in Q1 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Asset Allocation Strategies reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Asset Allocation Strategies sold 8,284 Pfizer shares in Q2 2026, an estimated $233K.
  • Asset Allocation Strategies first reported a position in Pfizer in Q4 2022 and held it in 8 quarters.
  • Asset Allocation Strategies's Pfizer position peaked at $389K in Q1 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Asset Allocation Strategies's 13F filing for Q2 2026, filed 17 Aug 2026.